Skip to main content

Daniel G. Salvadori

Equibles does not estimate personal net worth.

Get an email with a short summary when Abbott Laboratories publishes a filing, an earnings call transcript or a press release.

Get ABT alerts

About Daniel G. Salvadori

The proxy statement of Abbott Laboratories reports total compensation of $6,534,285 for Daniel G. Salvadori in fiscal 2025, including a base salary of $924,231. Disclosed compensation is on record for 7 fiscal years. Abbott Laboratories is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Abbott Laboratories includes Robert B. Ford (CEO, Chairman and Board Member), Philip P. Boudreau (CFO), Robert E. Funck, Jr. (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Abbott Laboratories

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Abbott Laboratories (ABT) $924,231 $6,534,285
2024 Abbott Laboratories (ABT) $879,269 $5,789,762
2023 Abbott Laboratories (ABT) $790,000 $5,934,830
2022 Abbott Laboratories (ABT) $790,000 $7,157,684
2021 Abbott Laboratories (ABT) $715,539 $6,742,299
2020 Abbott Laboratories (ABT) $710,000 $5,975,739
2019 Abbott Laboratories (ABT) $704,923 $6,767,814

Recent activity

No call appearances or filed executive changes recorded yet.